Diabetes Care Management Becoming an Increased Priority for Health Insurers across New England

New England Health Plan Analysis Now Available from HealthLeaders-InterStudy

NASHVILLE, Tenn.--(BUSINESS WIRE)-- HealthLeaders-InterStudy, a leading provider of managed care market intelligence, reports that diabetes care management is becoming an increased priority for health insurers across New England. According to the recent New England Health Plan Analysis, the rising cost of diabetes management is pushing insurers to search for ways to lower costs.

The report finds that health plans are beginning to move beyond the traditional approaches to diabetes disease management, such as reliance on case managers, and are instead focusing on medication therapy management programs for both pre-diabetic and diabetic patients. As health plans stress the importance of physicians’ involvement in patient care management for diabetics, pharmaceutical companies will see a boost in sales of prescription maintenance drugs.

“Across New England, in an effort to combat the rising costs of diabetes care, more carriers have embraced a holistic view of diabetes management, looking at the full health spectrum to elevate members' health status,” said Ric Gross, senior market analyst with HealthLeaders-InterStudy. “As such, utilization management will become a key focus for health plans throughout New England with continued emphasis on quantity limits and generic substitution. Drugs that can exhibit greater patient compliance have the best chance of success.”

Other topics highlighted in the recent New England Health Plan Analysis include:

  • Medical loss ratio rules across the region and how individual states are impacted
  • The roll-out of new products in Massachusetts after the state’s tough year financially
  • How insurers are dealing with the rising cost of breast cancer drugs

Why Pharmaceutical Company Managed Markets Teams Need Health Plan Analysis

Health Plan Analysis identifies key health plan trends, allowing pharmaceutical companies to create comprehensive strategic plans and sales strategies at state and local levels. Updated quarterly, Health Plan Analysis provides a detailed look at plan design and financials, as well as information about mergers, legislation and other influencers driving healthcare in a particular region.

About HealthLeaders-InterStudy

HealthLeaders-InterStudy, a Decision Resources, Inc. company, is the authoritative source for managed care data, analysis and news. For more information, please visit www.HL-ISY.com.

About Decision Resources, Inc.

Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources, Inc. at www.DecisionResourcesInc.com.

All company, brand or product names contained in this document may be trademarks or registered trademarks of their respective holders.



CONTACT:

HealthLeaders-InterStudy
Erin O’Leary, 781-993-2641
[email protected]
or
Decision Resources, Inc.
Elizabeth Marshall, 781-993-2563
[email protected]

KEYWORDS:   United States  North America  Tennessee

INDUSTRY KEYWORDS:   Technology  Data Management  Health  Oncology  Pharmaceutical  Professional Services  Insurance  Diabetes  General Health  Managed Care

MEDIA:

Suggested Articles

Humana filed suit Friday against more than a dozen generic drugmakers alleging the companies engaged in price fixing.

Nominations are open for our 2020 FierceHealthcare Fierce 15 awards. Think your company has what it takes? Submit your nominations here.

Medicare Advantage open enrollment kicked off last week, and insurers are taking new approaches to marketing a slate of supplemental benefit options.